A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.
Inclusion Criteria:
Exclusion Criteria: